Skip to main content
Erschienen in: Annals of Hematology 9/2017

27.06.2017 | Letter to the Editor

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients

verfasst von: Hiroshi Ureshino, Kazuharu Kamachi, Masaharu Miyahara

Erschienen in: Annals of Hematology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Harashima N (2004) Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64:391–399CrossRefPubMed Harashima N (2004) Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64:391–399CrossRefPubMed
2.
Zurück zum Zitat Takamori A, Hasegawa A, Utsunomiya A et al (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8:100CrossRefPubMedPubMedCentral Takamori A, Hasegawa A, Utsunomiya A et al (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8:100CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Suehiro Y, Hasegawa A, Iino T et al (2015) Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br J Haematol 169:356–367CrossRefPubMed Suehiro Y, Hasegawa A, Iino T et al (2015) Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br J Haematol 169:356–367CrossRefPubMed
4.
Zurück zum Zitat Sugiyama D, Nishikawa H, Maeda Y, et al (2013) Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A 110:17945–17950. Sugiyama D, Nishikawa H, Maeda Y, et al (2013) Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A 110:17945–17950.
5.
Zurück zum Zitat Sugata K, Yasunaga J-I, Miura M et al (2016) Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep 6:27150CrossRefPubMedPubMedCentral Sugata K, Yasunaga J-I, Miura M et al (2016) Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep 6:27150CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fukushima T, Nomura S, Shimoyama M et al (2014) Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166:739–748CrossRefPubMed Fukushima T, Nomura S, Shimoyama M et al (2014) Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166:739–748CrossRefPubMed
7.
Zurück zum Zitat Ishida T, Jo T, Takemoto S et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672–682CrossRefPubMedPubMedCentral Ishida T, Jo T, Takemoto S et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672–682CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ureshino H, Shindo T, Nishikawa H et al (2016) Effector regulatory T cells reflect the equilibrium between antitumor immunity and autoimmunity in adult T-cell leukemia. Cancer Immunol Res 4:644–649CrossRefPubMed Ureshino H, Shindo T, Nishikawa H et al (2016) Effector regulatory T cells reflect the equilibrium between antitumor immunity and autoimmunity in adult T-cell leukemia. Cancer Immunol Res 4:644–649CrossRefPubMed
Metadaten
Titel
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients
verfasst von
Hiroshi Ureshino
Kazuharu Kamachi
Masaharu Miyahara
Publikationsdatum
27.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 9/2017
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3052-4

Weitere Artikel der Ausgabe 9/2017

Annals of Hematology 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.